Connect to other sites within the UBM Medica Network
Gene mutations reflect smoking history in patients with HPV-positive oropharyngeal cancer. Image © Magic Pictures/Shutterstock.com
Astex, Genentech to Study Guadecitabine Plus Atezolizumab Treatment for AML
Genentech and Astex Pharmaceuticals will collaborate in a clinical trial of a combination hypomethylating and immune checkpoint blockade therapy for patients with acute myeloid leukemia.
Cabozantinib Receives FDA Approval for Treating Advanced RCC
Clinicians now have a new targeted therapy option for treating patients with advanced renal cell carcinoma (RCC) who have received prior antiangiogenic therapy.
Liver Nodule Found in 35-Year-Old Woman
A 35-year-old woman was found to have a 4 cm nodule in the liver. After a biopsy is performed, what is your diagnosis?
Gene Mutations Lead to Tissue Tension in Pancreatic Cancer
For the first time, researchers suggest that underlying genetic mutations may cause pancreatic adenocarcinoma tumors to stiffen up and produce a dangerous thickening and scarring of the tissue around them.
Right Arm Lesion Found in 37-Year-Old Man
A 37-year old man presents with a bluish lesion in the right arm. After further assessment, a biopsy is performed. What is your diagnosis?
AACR: Merkel Cell Carcinoma Responsive to Anti-PD-1 Immunotherapy
Patients with metastatic Merkel cell carcinoma treated with pembrolizumab (Keytruda, Merck) as a first-line therapy had durable responses in a phase II clinical trial.
AACR: Novel Targeted Therapy Showing Activity in NSCLC and Ovarian Cancers
NEW ORLEANS – A new type of antibody-drug conjugate (ADC) platform may pave the way to help patients with ovarian cancer and non-small cell lung cancer.
March 2016 News Recap
In case you missed it, check out our March recap featuring some of the latest in clinical trial news, a new indication for Afinitor, how genetics affect prognosis, and more.
Epidermal Growth Factor Receptor Inhibitor Cutaneous Side Effects
This slide show highlights some of the cutaneous side effects related to the use of epidermal growth factor receptor inhibitors (EGFRI).
Slide Show: Highlights From the 2015 ASCO Breast Cancer Symposium
This slide show highlights some of the presentations that took place at the 2015 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium in San Francisco, September 25-27, 2015.
Slide Show: Trends in Targeted Therapies and Immunotherapies
This slide show provides information on the present and future of targeted therapies and immunotherapies based on a report from the IMS Institute for Healthcare Informatics.
By clicking Accept, you agree to become a member of the UBM Medica Community.